Fusion Pharma LLC   Report issue

For profit Phase 1 Phase 2
Founded: Moscow Russian Federation (2010)
Status: Acquired by Arpida AG (2009) → now Evolva SA (2009)

Organization Overview

First Clinical Trial
2016
NCT02885766
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2019

Timeline

NOW
  • Now

Mergers & Acquisitions

Historical Acquisition Tree

Alternative names

Fusion Pharmaceuticals